Assenagon Asset Management
APEN

Assenagon Asset Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Assenagon Asset Management’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-207,842
Closed -$1.15M – 1492
2022
Q3 		$1.15M Hold
207,842
– – ﹤0.01% 898
2022
Q2 		$759K Sell
207,842
-82
-0% -$388 ﹤0.01% 1147
2022
Q1 		$1.26M Sell
207,924
-184,131
-47% -$1.12M ﹤0.01% 995
2021
Q4 		$3.31M Buy
392,055
+156,109
+66% +$1.36M 0.01% 637
2021
Q3 		$2.14M Buy
235,946
+7,971
+3% +$68.5K 0.01% 670
2021
Q2 		$1.85M Buy
+227,975
New +$1.56M 0.01% 701

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Assenagon Asset Management's APEN Position: Q4 2022 in Review

Assenagon Asset Management sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2022, closing a stake of 207,842 shares — an estimated $1.15M sold.

Assenagon Asset Management first reported a position in APEN in Q2 2021 and held it in 6 quarters. The position peaked at $3.31M in Q4 2021. 81 funds tracked by Wall St. Rank hold APEN as of Q4 2022.

  • Assenagon Asset Management reported no remaining Apollo Endosurgery, Inc. position as of Q4 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 207,842 Apollo Endosurgery, Inc. shares in Q4 2022, an estimated $1.15M.
  • Assenagon Asset Management first reported a position in Apollo Endosurgery, Inc. in Q2 2021 and held it in 6 quarters.
  • Assenagon Asset Management's Apollo Endosurgery, Inc. position peaked at $3.31M in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2022.

Based on Assenagon Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.